Eversheds Sutherland advises MicroAire Surgical Instruments on the acquisition of Neosyad
February 05, 2025
Eversheds Sutherland advises MicroAire Surgical Instruments on the acquisition of NeosyadFebruary 05, 2025 Our team in France has advised MicroAire Surgical Instruments LLC on its acquisition of Neosyad, an innovative French medical device company which specialises in adipose tissue engineering. MicroAire Surgical Instruments LLC is a global leader in surgical power tools and medical devices, headquartered in Charlottesville, Virginia. Neosyad is an innovative French medical device company in adipose tissue engineering for reconstructive and plastic surgery applications. The sale was completed by Neosyad’s co-founders and minority shareholders. This strategic transaction enhances MicroAire’s capabilities in the field of medical device innovation, strengthening its market presence and expanding its expertise in adipose tissue engineering technology. In Paris, the Eversheds Sutherland team was led by Franck Bourgeois (partner), Doriane Shannon (senior associate) and Benjamin Grunebaum (associate) for the corporate/M&A aspects of the transaction. The due diligences of the transaction involved Gaëtan Cordier (partner) and Brian Robion (associate) for intellectual property as well as Deborah Attali (partner), Anne Cognet (counsel) and Nicolas Etcheparre (counsel) in employment law. The sellers were assisted by Akléa in Corporate, M&A and IT law. Investment bank: Hottinguer. Latest Insights
Latest News
Latest Events
firm news July 10, 2026 Eversheds Sutherland advises OCBC on the landmark secondary dual listing of... client news July 10, 2026 Setting sail: Eversheds Sutherland advises senior management of D-Marin on ... client news July 09, 2026 Eversheds Sutherland advises Costello Medical on transition to employee own... firm news July 01, 2026 Eversheds Sutherland lands lateral partner-led Paris Funds team, as its wid... virtual UAE - Employment law in the Dubai International Financial Centre September 10, 2026 9.30am - 1.30pm (GMT) Virtual in-person September 10, 2026 9.30am - 1.00pm (BST) London, United Kingdom in-person September 17, 2026 9.30am - 4.30pm (GMT) London, United Kingdom in-person September 23, 2026 Washington DC, United States |